A detailed history of Hemington Wealth Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 4,698 shares of MRK stock, worth $533,504. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,698
Previous 4,612 1.86%
Holding current value
$533,504
Previous $609,000 4.6%
% of portfolio
0.2%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $10,646 - $11,434
86 Added 1.86%
4,698 $581,000
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $11,097 - $12,931
-98 Reduced 2.08%
4,612 $609,000
Q4 2023

Jan 26, 2024

BUY
$100.18 - $109.02 $100,680 - $109,565
1,005 Added 27.13%
4,710 $513,000
Q3 2023

Oct 20, 2023

SELL
$102.95 - $114.33 $32,944 - $36,585
-320 Reduced 7.95%
3,705 $381,000
Q2 2023

Aug 04, 2023

SELL
$108.61 - $118.38 $23,459 - $25,570
-216 Reduced 5.09%
4,025 $464,000
Q1 2023

May 05, 2023

SELL
$102.94 - $114.86 $17,190 - $19,181
-167 Reduced 3.79%
4,241 $451,000
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $33,751 - $43,274
-386 Reduced 8.05%
4,408 $489,000
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $63,904 - $71,789
756 Added 18.72%
4,794 $413,000
Q2 2022

Jul 22, 2022

SELL
$83.49 - $94.64 $671,259 - $760,905
-8,040 Reduced 66.57%
4,038 $368,000
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $50,942 - $57,103
693 Added 6.09%
12,078 $991,000
Q4 2021

Jan 13, 2022

SELL
$72.28 - $90.54 $52,619 - $65,913
-728 Reduced 6.01%
11,385 $931,000
Q3 2021

Oct 06, 2021

SELL
$71.68 - $78.83 $6,379 - $7,015
-89 Reduced 0.73%
12,113 $910,000
Q2 2021

Jul 09, 2021

SELL
$70.31 - $77.77 $18,421 - $20,375
-262 Reduced 2.1%
12,202 $949,000
Q1 2021

Apr 12, 2021

BUY
$68.86 - $81.11 $74,299 - $87,517
1,079 Added 9.48%
12,464 $961,000
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $817,101 - $906,815
11,385 New
11,385 $931,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.